# Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion

> **NCT05821842** · NA · COMPLETED · sponsor: **Third Wave Therapeutics** · enrollment: 52 (actual)

## Conditions studied

- Nasal Congestion and Inflammations

## Interventions

- **DEVICE:** Sonu

## Key facts

- **NCT ID:** NCT05821842
- **Lead sponsor:** Third Wave Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-23
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05821842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05821842, "Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05821842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*